Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jclinepi.2010.11.021
DC FieldValue
dc.titleAssessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program
dc.contributor.authorAtkins, D.
dc.contributor.authorChang, S.M.
dc.contributor.authorGartlehner, G.
dc.contributor.authorBuckley, D.I.
dc.contributor.authorWhitlock, E.P.
dc.contributor.authorBerliner, E.
dc.contributor.authorMatchar, D.
dc.date.accessioned2014-11-26T09:05:54Z
dc.date.available2014-11-26T09:05:54Z
dc.date.issued2011-11
dc.identifier.citationAtkins, D., Chang, S.M., Gartlehner, G., Buckley, D.I., Whitlock, E.P., Berliner, E., Matchar, D. (2011-11). Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program. Journal of Clinical Epidemiology 64 (11) : 1198-1207. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jclinepi.2010.11.021
dc.identifier.issn08954356
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110690
dc.description.abstractObjective: To describe a systematic approach for identifying, reporting, and synthesizing information to allow consistent and transparent consideration of the applicability of the evidence in a systematic review according to the Population, Intervention, Comparator, Outcome, Setting domains. Study Design and Setting: Comparative effectiveness reviews need to consider whether available evidence is applicable to specific clinical or policy questions to be useful to decision makers. Authors reviewed the literature and developed guidance for the Effective Health Care program. Results: Because applicability depends on the specific questions and needs of the users, it is difficult to devise a valid uniform scale for rating the overall applicability of individual studies or body of evidence. We recommend consulting stakeholders to identify the factors most relevant to applicability for their decisions. Applicability should be considered separately for benefits and harms. Observational studies can help determine whether trial populations and interventions are representative of "real world" practice. Reviewers should describe differences between available evidence and the ideally applicable evidence for the question being asked and offer a qualitative judgment about the importance and potential effect of those differences. Conclusion: Careful consideration of applicability may improve the usefulness of systematic reviews in informing practice and policy. © 2011 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.jclinepi.2010.11.021
dc.sourceScopus
dc.subjectApplicability
dc.subjectComparative effectiveness
dc.subjectExternal validity
dc.subjectGeneralizability
dc.subjectHeterogeneity of treatment effect
dc.subjectSystematic review
dc.typeReview
dc.contributor.departmentDUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
dc.description.doi10.1016/j.jclinepi.2010.11.021
dc.description.sourcetitleJournal of Clinical Epidemiology
dc.description.volume64
dc.description.issue11
dc.description.page1198-1207
dc.description.codenJCEPE
dc.identifier.isiut000295605000006
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.